Zai Lab Ltd (NASDAQ:ZLAB)
| 24.47 Delayed Data As of 3:59pm ET |  +0.49 / +2.04%Today’s Change | 20.98 Today|||52-Week Range 49.81 | -20.29% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.5B |
Company Description
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Contact Information
Zai Lab Ltd. Jinchuang Plaza Shanghai Shanghai 201210 |
Employees
Shareholders
| Mutual fund holders | 25.36% |
| Other institutional | 18.92% |
| Individual stakeholders | -- |
Top Executives
| Ying Du | Chairman & Chief Executive Officer |
| Joshua L. Smiley | President & Chief Operating Officer |
| Ya jing Chen | Chief Financial & Accounting Officer |
| Ning Xu | Executive VP & Head-Clinical Operations |
| James Yan | Chief Operating Officer-Research & Development |
